EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of pulmonary hypertension on outcomes after TEER in patients suffering from mitral regurgitation

Philippa Jaeger, Ioannis Toskas, Jessica-Kristin Henes, Serhii Shcherbyna, Frederic Schwarz, Miriam Euper, Peter Seizer, Harald Langer, Andreas E May, Tobias Geisler, Meinrad Gawaz, Jürgen Schreieck und 1 weitere

Clinical Research in Cardiology · 2025-02 · 114 (2) · 203-214

DOI: 10.1007/s00392-024-02442-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Research in Cardiology, online erschienen am 02.04.2024. Verfasst von Philippa Jaeger und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Hypertension, Pulmonary, Cardiac Catheterization, Mitral Valve. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Tübingen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Data on associations of invasively determined hemodynamic parameters with procedural success and outcomes in patients suffering from mitral regurgitation (MR) undergoing transcatheter edge-to-edge repair of the mitral valve (M-TEER) is limited. Methods and results We enrolled 239 patients with symptomatic MR of grade 2 + , who received M-TEER. All patients underwent extensive pre-interventional invasive hemodynamic measurements via right heart catheterization (mean pulmonary arterial pressure (mPAP), systolic- (PAPsys) and diastolic pulmonary arterial pressure (PAPdia), pulmonary arterial wedge pressure (PAWP), a-wave, v-wave, pulmonary vascular resistance (PVR), transpulmonary pressure gradient (TPG), cardiac index (CI), stroke volume index (SVI)). mPAP and PAWP at baseline were neither associated with procedural success, immediate reduction of MR, nor residual MR after 6 months of follow-up. The composite outcome (All-cause mortality (ACM) and/or heart failure induced rehospitalization (HFH)) and HFH differed significantly after M-TEER when stratified according to mPAP, PAWP, PAPdia, a-wave and v-wave. ACM was not associated with the afore mentioned parameters. Neither PVR, TPG, CI nor SVI were associated with the composite outcome and HFH, respectively. In multivariable analyses, PAWP was independently associated with the composite outcome and HFH. PVR and SVI were not associated with outcomes.

Conclusion

PAWP at baseline was significantly and independently associated with HFH and might serve as a valuable parameter for identifying patients at high risk for HFH after M-TEER. ACM and procedural success were not affected by pulmonary arterial pressure before M-TEER. We suggest that the post-capillary component of PH serves as the driving force behind the risk of HFH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyHypertension, PulmonaryCardiac CatheterizationMitral ValveHeart Valve Prosthesis ImplantationHumansMaleFemaleAgedTreatment OutcomeMiddle AgedPulmonary Wedge PressureFollow-Up StudiesHemodynamicsRetrospective Studies

Stichwörter der Autor:innen

Mitral valve transcatheter edge-to-edge repairOutcome AssessmentPulmonary Arterial Hypertension

Autor:innen und Institutionen

  • Department of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
  • Departmen of Cardiology and Angiology, Ostalb-Klinikum, Aalen, Germany.
  • Department of Medicine, Cardiology, Angiology, Hemostasis and Intensive Care Medicine, University Medical Center Mannheim, Mannheim, Germany.
  • Medizinische Klinik I, Klinikum Memmingen, Mannheim, Germany.
  • Department of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany. dominik.rath@med.uni-tuebingen.de.

Förderung

  • Universitätsklinikum Tübingen

Zitieren

APA

Jaeger, P., Toskas, I., Henes, J. K., Shcherbyna, S., Schwarz, F., Euper, M., Seizer, P., Langer, H., May, A. E., Geisler, T., Gawaz, M., Schreieck, J., & Rath, D. (2025). Impact of pulmonary hypertension on outcomes after TEER in patients suffering from mitral regurgitation. Clinical Research in Cardiology, 114(2), 203-214. https://doi.org/10.1007/s00392-024-02442-1

Vancouver

Jaeger P, Toskas I, Henes JK, Shcherbyna S, Schwarz F, Euper M, et al. Impact of pulmonary hypertension on outcomes after TEER in patients suffering from mitral regurgitation. Clinical Research in Cardiology. 2025;114(2):203-214. doi:10.1007/s00392-024-02442-1

BibTeX
@article{Jaeger2025,
  author = {Jaeger, Philippa and Toskas, Ioannis and Henes, Jessica-Kristin and Shcherbyna, Serhii and Schwarz, Frederic and Euper, Miriam and Seizer, Peter and Langer, Harald and May, Andreas E and Geisler, Tobias and Gawaz, Meinrad and Schreieck, Jürgen and Rath, Dominik},
  title = {Impact of pulmonary hypertension on outcomes after TEER in patients suffering from mitral regurgitation},
  journal = {Clinical Research in Cardiology},
  year = {2025},
  volume = {114},
  number = {2},
  pages = {203--214},
  doi = {10.1007/s00392-024-02442-1}
}
Kostenlos starten →